Evidence map›Paper›PMID 30265290›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Pneumococcal and Legionella Urinary Antigen Tests in Community-acquired Pneumonia: Prospective Evaluation of Indications for Testing.

Shawna Bellew, Carlos G Grijalva, Derek J Williams, Evan J Anderson, Richard G Wunderink, Yuwei Zhu, Grant W Waterer, Anna M Bramley, Seema Jain, Kathryn M Edwards and 1 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. My approach to respiratory sepsis: pulmonary.Breathe (Sheffield, England) · 2026
    Review
  5. Community-AcquiredPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Review
  12. Article
  13. Severe Legionnaires' disease.Annals of intensive care · 2024
    Review
  14. Things We Do for No Reason - OrderingOpen forum infectious diseases · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Shawna BellewVanderbilt University Medical Center, Nashville, Tennessee.
Carlos G GrijalvaVanderbilt University Medical Center, Nashville, Tennessee.
Derek J WilliamsVanderbilt University Medical Center, Nashville, Tennessee.
Evan J AndersonEmory University School of Medicine, Atlanta, Georgia.
Richard G WunderinkNorthwestern University Feinberg School of Medicine, Chicago, Illinois.
Yuwei ZhuVanderbilt University Medical Center, Nashville, Tennessee.
Grant W WatererUniversity of Western Australia, Perth.
Anna M BramleyCenters for Disease Control and Prevention, Atlanta, Georgia.
Seema JainCenters for Disease Control and Prevention, Atlanta, Georgia.
Kathryn M EdwardsVanderbilt University Medical Center, Nashville, Tennessee.
Wesley H SelfVanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt University Medical Center · USCenters for Disease Control and Prevention · USEmory University · USNorthwestern University · USUniversity of Western Australia · AU

Funding

Technology CoreU19AI135964 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JUSTIN B. STARREN · 2018 to 2026
$24.7M
Opioid selection and the risk of serious infections in older adultsR01AG043471 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GRIJALVA, CARLOS G · 2013 to 2017
$2.3M
Salivary Cortisol as a Marker of Community-Acquired Pneumonia Severity in AdultsK23GM110469 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SELF, WESLEY H · 2015 to 2018
$683k
NCIRD CDC HHS U18 IP000299NIAID NIH HHS U19 AI135964NIA NIH HHS R01 AG043471NIGMS NIH HHS K23 GM110469
6 · The paper itself

Abstract

backgroundAdult, community-acquired pneumonia (CAP) guidelines from the Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) include indications for urinary antigen tests (UATs) for Streptococcus pneumoniae (SP) and Legionella pneumophila (LP). These recommendations were based on expert opinions and have not been rigorously evaluated.

methodsWe used data from a multicenter, prospective, surveillance study of adults hospitalized with CAP to evaluate the sensitivity and specificity of the IDSA/ATS UAT indications for identifying patients who test positive. SP and LP UATs were completed on all included patients. Separate analyses were completed for SP and LP, using 2-by-2 contingency tables, comparing the IDSA/ATS indications (UAT recommended vs not recommended) and UAT results (positive vs negative). Additionally, logistic regression was used to evaluate the association of each individual criterion in the IDSA/ATS indications with positive UAT results.

resultsAmong 1941 patients, UATs were positive for SP in 81 (4.2%) and for LP in 32 (1.6%). IDSA/ATS indications had 61% sensitivity (95% confidence interval [CI] 49-71%) and 39% specificity (95% CI 37-41%) for SP, and 63% sensitivity (95% CI 44-79%) and 35% specificity (95% CI 33-37%) for LP. No clinical characteristics were strongly associated with positive SP UATs, while features associated with positive LP UATs were hyponatremia, fever, diarrhea, and recent travel.

conclusionsRecommended indications for SP and LP urinary antigen testing in the IDSA/ATS CAP guidelines have poor sensitivity and specificity for identifying patients with positive tests; future CAP guidelines should consider other strategies for determining which patients should undergo urinary antigen testing.

Indexed as

Immunologic TestsAgedAged, 80 and overAntigens, BacterialBiomarkersCommunity-Acquired InfectionsCross-Sectional StudiesFemaleHumansLegionnaires' DiseaseMaleMiddle AgedPneumonia, PneumococcalPublic Health SurveillanceSensitivity and SpecificityUrinalysisAntigens, BacterialBiomarkersLegionellapneumococcalpneumoniaurine antigen test

Identifiers

PMID30265290
PMCPMC7182343
OpenAlexW2893272392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.